Skip to content

phacoemulsification with IOL implantation combined CO2 Laser-assisted Deep Sclerectomy in the therapy of cataract combined with glaucoma: assessment of efficacy and safety

phacoemulsification with IOL implantation combined CO2 Laser-assisted Deep Sclerectomy in the therapy of cataract combined with glaucoma: assessment of efficacy and safety

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONN-16008990
Enrollment
Unknown
Registered
2016-08-08
Start date
2015-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glaucoma and cataract

Interventions

Cataract surgery combind with CLASS:Cataract surgery combind with CLASS

Sponsors

Department of Ophthalmology, Research Institute of Surgery&Daping Hospital, Third Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Adult patients(aged 18y or above) of both sexes; 2. Signed inform consent forms; 3. With clinical diagnosis of medically uncontrolled glaucoma combined with cataract; Medically uncontrolled glaucoma was defined as well-documented progression of visual field defects and glaucomatous optic nerve morphology, including thinning or notching of the neuroretinal rim accompanied by localized or diffuse retinal nerve fiber layer loss, and accompanied by correlated typical glaucomatous visual field loss.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of an earlier intraocular surgery; 2. Patients with no light perception; 3. Retinal disease.

Design outcomes

Primary

MeasureTime frame
IOP;the number of IOP-lowering drug;

Secondary

MeasureTime frame
BCVA;surgical complication;counts of corneal endothelial cells;

Countries

China

Contacts

Public ContactJian Ye

Department of Ophthalmology, Research Institute of Field Surgery, Da Ping Hospital, Third Military Medical University

yejian1979@163.com+86 023 68757766

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026